首页> 美国卫生研究院文献>Biophysical Journal >Combined and Independent Action of Proteins SP-B and SP-C in the Surface Behavior and Mechanical Stability of Pulmonary Surfactant Films
【2h】

Combined and Independent Action of Proteins SP-B and SP-C in the Surface Behavior and Mechanical Stability of Pulmonary Surfactant Films

机译:蛋白质SP-B和SP-C在肺表面活性剂膜的表面行为和机械稳定性中的联合和独立作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The hydrophobic proteins SP-B and SP-C are essential for pulmonary surfactant function, even though they are a relatively minor component (<2% of surfactant dry mass). Despite countless studies, their specific differential action and their possible concerted role to optimize the surface properties of surfactant films have not been completely elucidated. Under conditions kept as physiologically relevant as possible, we tested the surface activity and mechanical stability of several surfactant films of varying protein composition in vitro using a captive bubble surfactometer and a novel (to our knowledge) stability test. We found that in the naturally derived surfactant lipid mixtures, surfactant protein SP-B promoted film formation and reextension to lower surface tensions than SP-C, and in particular played a vital role in sustaining film stability at the most compressed states, whereas SP-C produced no stabilization. Preparations containing both proteins together revealed a slight combined effect in enhancing film formation. These results provide a qualitative and quantitative framework for the development of future synthetic therapeutic surfactants, and illustrate the crucial need to include SP-B or an efficient SP-B analog for optimal function.
机译:疏水蛋白SP-B和SP-C对于肺表面活性剂功能是必不可少的,即使它们是相对较小的成分(<表面活性剂干质量的<2%)。尽管进行了无数研究,但尚未完全阐明它们的特定差异作用及其在优化表面活性剂膜表面性能方面可能起到的协同作用。在尽可能保持生理相关性的条件下,我们使用俘获气泡表面张力计和新颖的(据我们所知)稳定性测试了几种蛋白质组成不同的表面活性剂薄膜的表面活性和机械稳定性。我们发现,在天然来源的表面活性剂脂质混合物中,表面活性剂蛋白SP-B促进了膜的形成和再延伸,从而使其表面张力低于SP-C,尤其在维持大多数压缩状态下的膜稳定性方面起着至关重要的作用,而SP- C没有产生稳定作用。包含两种蛋白质的制剂显示出在增强膜形成方面的轻微联合作用。这些结果为未来合成治疗性表面活性剂的开发提供了定性和定量的框架,并说明了为达到最佳功能而必须包含SP-B或高效SP-B类似物的关键需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号